SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001558370-17-001331
Filing Date
2017-03-03
Accepted
2017-03-03 16:16:32
Documents
78
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 imgn-20161231x10k.htm 10-KT 3380413
2 imgn-20161231ex1028911ab.htm EX-10.28 111421
3 imgn-20161231xex23.htm EX-23 3669
4 imgn-20161231ex311ff4ad6.htm EX-31.1 21168
5 imgn-20161231ex312a2817e.htm EX-31.2 17860
6 imgn-20161231xex32.htm EX-32 15059
  Complete submission text file 0001558370-17-001331.txt   13603103

Data Files

Seq Description Document Type Size
7 imgn-20161231.xml EX-101.INS 3226129
8 imgn-20161231.xsd EX-101.SCH 70871
9 imgn-20161231_cal.xml EX-101.CAL 70584
10 imgn-20161231_def.xml EX-101.DEF 297542
11 imgn-20161231_lab.xml EX-101.LAB 648666
12 imgn-20161231_pre.xml EX-101.PRE 547027
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-KT | Act: 34 | File No.: 000-17999 | Film No.: 17663762
SIC: 2834 Pharmaceutical Preparations